Uncovering Risk Factors of Premature Mortality in Common Variable Immunodeficiency

Area of Science:

• Immunology
• Clinical Medicine
• Genetics

Background:

• Common variable immunodeficiency (CVID) patients with immune dysregulation complications (CVIDc) exhibit increased mortality compared to infection-only (CVIDio) cases.
• Identifying predictors of premature death in CVIDc is critical for improved patient outcomes.

Purpose of the Study:

• To analyze mortality patterns in a large tertiary referral center.
• To compare clinical and laboratory features of deceased CVIDc patients with matched living controls to identify premature death indicators.

Main Methods:

• Retrospective case-control study of CVID patients meeting European Society for Immunodeficiencies criteria.
• Cases were CVIDc patients who died before age 70; controls were matched for sex, age, and CVID phenotype.

Main Results:

• Confirmed poorer prognosis for CVIDc versus CVIDio (57 deaths in 497 patients).
• Infections and neoplasia were leading causes of death.
• Cases showed higher prevalence of severe enteropathy, hepatopathy, and neoplasia, with increased lymphopenia, thrombocytopenia, and liver enzyme elevation three years prior to death.

Conclusions:

• Severe enteropathy and hepatopathy are potential key factors associated with premature mortality in CVIDc.
• Further multicenter, prospective studies are needed to confirm these findings.
• Early evaluation of these factors may lead to improved treatment strategies for CVIDc.